Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 861

1.

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, Chalmers J; PROGRESS Collaborative Group..

Arch Intern Med. 2003 May 12;163(9):1069-75.

PMID:
12742805
2.

Vascular factors and cognition: toward a prevention of dementia?

Tzourio C.

J Hypertens Suppl. 2003 Jun;21(5):S15-9.

PMID:
12953851
5.

Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.

Chalmers J, MacMahon S.

J Hypertens Suppl. 2003 Jun;21(5):S9-14.

PMID:
12953850
6.

Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.

Berthet K, Neal BC, Chalmers JP, MacMahon SW, Bousser MG, Colman SA, Woodward M; Perindopril Protection Against Recurrent Stroke Study Collaborative Group..

Blood Press. 2004;13(1):7-13.

PMID:
15083634
7.
8.

PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.

Chalmers J, Neal B, MacMahon S; PROGRESS Management Committee..

J Hypertens Suppl. 2000 May;18(1):S13-9.

PMID:
10939785
9.
10.

Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.

Poon IO.

Pharmacotherapy. 2008 Mar;28(3):366-75. doi: 10.1592/phco.28.3.366. Review.

PMID:
18294116
11.
12.
14.

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial.

Arima H, Anderson C, Omae T, Liu L, Tzourio C, Woodward M, Macmahon S, Neal B, Rodgers A, Chalmers J; PROGRESS Collaborative Group..

J Hypertens. 2010 Feb;28(2):395-400. doi: 10.1097/HJH.0b013e328333b009.

PMID:
19864958
15.
16.

Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.

Dufouil C, Chalmers J, Coskun O, Besançon V, Bousser MG, Guillon P, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N, Tzourio C; PROGRESS MRI Substudy Investigators..

Circulation. 2005 Sep 13;112(11):1644-50. Epub 2005 Sep 6.

17.

Global impact of stroke.

Chalmers J.

Heart Dis. 2000 Mar-Apr;2(2):S13-7. Review.

PMID:
11728258
18.

ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.

Perkovic V, Joshi R, Patel A, Bompoint S, Chalmers J; ADVANCE Collaborative Group..

Blood Press. 2006;15(6):340-6.

PMID:
17472024
19.

Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.

Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, Colman S, Davis S, Donnan G, MacMahon S, Neal B, Warlow C, Woodward M; Writing Committee for the PROGRESS Collaborative Group..

Stroke. 2004 Jan;35(1):116-21. Epub 2003 Dec 11.

Supplemental Content

Support Center